Skip to main content
All lobbying filings

CASE WESTERN RESERVE UNIVERSITY

CASE WESTERN RESERVE UNIVERSITY filed a Q3 report for CASE WESTERN RESERVE UNIVERSITY on October 20, 2026.

Lobbying for CASE WESTERN RESERVE UNIVERSITY

All filings by CASE WESTERN RESERVE UNIVERSITY · Everything CASE WESTERN RESERVE UNIVERSITY has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Expenses
$120,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Ohio

Official filing document

 Lobbyists on this filing 1
  • SEAN FRANCIS LOWE
    Previously held: Rep. Tim Ryan (Ohio) from 2019-2021

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 8

- General issues related to student visas. - General issues related to international students. - Duration of status policy.

- Issues related to Regulation for Federal Financial Assistance (Uniform Guidance) in HR 6500, Continuing Appropriations and Extensions Act, 2027.

- Issues related to indirect cost recovery.

- General support for Federal TRIO Programs.

- Issued related to Congressionally Directed Medical Research Programs (CDMRP) - Issued related to the importance of peer-reviewed biomedical research. - Support for additional research into the impact of glial cells on neurodegenerative diseases, gastrointestinal diseases, and brain cancers in FY27 House and Senate Labor, Health and Humman Services funding package. - Issues related to indirect cost recovery.

- Issues related to Regulation for Federal Financial Assistance (Uniform Guidance) in HR 6500 Continuing Appropriations and Extensions Act, 2027. - Support for increased funding for the Congressionally Directed Medical Research Programs (CDMRP) in FY27 House and Senate Defense funding package. - Funding support for biotechnology commercialization efforts in FY27 House and Senate Commerce, Justice, Science funding package. - Support for hypersonic research, testing, and diagnostic development in FY27 House and Senate Defense funding package. - Support for additional research into the impact of glial cells on neurodegenerative diseases, gastrointestinal diseases, and brain cancers in FY27 House and Senate Labor, Health and Humman Services funding package. - Issues related to indirect cost recovery.

- Issued related to Congressionally Directed Medical Research Programs (CDMRP). - Basic research surrounding domestic critical metals production for defense applications in FY27 House and Senate Defense funding package. - Support for hypersonic research, testing, and diagnostic development in FY27 House and Senate Defense funding package. - Issues related to indirect cost recovery.

- Funding support for biotechnology commercialization efforts in FY27 House and Senate Commerce, Justice, Science funding package. - Issues related to indirect cost recovery.

 Bills named in this filing 1
  • H.R. 6500
    Continuing Appropriations and Extensions Act, 2027

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem